The Vision Council Releases Provider inSights Q1 2022 Report

By Staff
Wednesday, May 18, 2022 12:24 AM ALEXANDRIA, Va.—The Vision Council today releases the Provider inSights Q1 2022 Report. The publication of the report continues the rollout of The Vision Council’s new inSights Research Program.

Visionix and Right MFG Enter Long-Term Strategic Partnership

By Staff
Tuesday, May 17, 2022 12:21 AM PARIS—Visionix and Right MFG. Co., Ltd. announced yesterday that they have entered a long-term strategic partnership agreement, expected to accelerate growth for both companies. Visionix will become the exclusive partner of Right MFG, and distribute Righton products in Europe, the Americas and Asia Pacific (excluding Japan and China).

Belkin Vision's Eagle Receives CE Mark Under Medical Device Regulation

By Staff
Tuesday, May 17, 2022 12:18 AM YAVNE, Israel—Belkin Vision, the Israel-based medical device company announced yesterday that it has been awarded CE Mark under Medical Device Regulation (MDR) from its notified body DEKRA, making it the first automated, non-contact glaucoma laser treatment available within Europe.

Carl Zeiss Meditec Reports Growth in First Half of 2021/22, Despite Strained Supply Chain

By Staff
Monday, May 16, 2022 12:24 AM JENA, Germany—Carl Zeiss Meditec generated revenue of €855.4 million in the first six months of the fiscal year ending March 31, 2022 versus €767.4 million the prior year, an 11.5 percent increase compared with the same period of the prior year (+10.7 percent adjusted for currency effects).

Bascom Palmer Receives Research to Prevent Blindness Medical Student Eye Research Fellowship

By Staff
Monday, May 16, 2022 12:15 AM MIAMI, Fla.—Bascom Palmer Eye Institute of the University of Miami Miller School of Medicine announced that Meher Saleem has received a Research to Prevent Blindness (RPB) Medical Student Eye Research Fellowship that will allow her to take a year off from medical school and to devote that time to pursue a research project at Bascom Palmer. Saleem earned a bachelor of arts degree from the University of Miami, magna cum laude, with a double major in chemistry and studio art.

Prevent Blindness Declares Third Annual Inherited Retinal Disease (IRD) Genetic Testing Week as May 16-22

By Staff
Friday, May 13, 2022 12:27 AM CHICAGO—Prevent Blindness has declared May 16-22, 2022 as the third annual “Inherited Retinal Disease (IRD) Genetic Testing Week.” Educational materials, such as a fact sheet, social media graphics, and a dedicated webpage, preventblindness.org/inherited-retinal-diseases/ are available. New this year to IRD Genetic Testing Week are two informational videos. Alina V. Dumitrescu, MD, clinical associate professor of ophthalmology and visual sciences, pediatric ophthalmology and strabismus, inherited eye disease at the University of Iowa hospitals and clinics, is featured in a new “IRD and Genetic Testing” episode in the Focus on Eye Health Expert Series.

Upneeq Wins Shape Magazine’s Best Professional-Treatment Product Award

By Staff
Thursday, May 12, 2022 12:18 AM BRIDGEWATER, N.J.—RVL Pharmaceuticals plc (Nasdaq: RVLP) announced that its FDA approved ptosis drug Upneeq (oxymetazoline hydrochloride ophthalmic solution), 0.1% was selected as the winner of “Best Professional Treatment Product” in the “Shape Healthy Beauty Awards.”

The Vision Council Releases Consumer inSights Q1 2022 Report

By Staff
Wednesday, May 11, 2022 12:24 AM ALEXANDRIA, Va.—The Vision Council today releases the Consumer inSights Q1 2022 Report, the first published report from The Vision Council’s new inSights Research Program, which was announced last week.

Bausch Health Companies Inc. Announces ‘Stable’ First-Quarter 2022 Results

By Staff
Wednesday, May 11, 2022 12:21 AM LAVAL, Quebec—Bausch Health Companies Inc. (NYSE/TSX: BHC) yesterday reported $1.918 billion in total revenue for the first quarter of 2022, as compared to $2.027 billion in the first quarter of 2021, a decrease of $109 million, or 5 percent.

MyVision Survey Reveals New Insights into How Pandemic Has Affected Consumer Vision Behavior and Attitudes

By Staff
Tuesday, May 10, 2022 12:26 PM The COVID pandemic has led to a growing number of eye issues over the last two years which have been identified in a newly released consumer survey conducted by MyVision.org, a group of expert ophthalmologists and optometrists whose purpose is to provide trusted information on eye health and vision. Yesterday’s Data Feed featured some key findings from MyVision’s survey. Here are some additional highlights.

Driving, in general, is already dangerous, but what MyVision found about drivers with poor eyesight is especially concerning. One out of three drivers say they’ve driven with an outdated eyesight prescription.

CooperVision Kicks Off 2022 Myopia Management Workshop Series

By Staff
Tuesday, May 10, 2022 12:21 AM SAN RAMON, Calif.—CooperVision, a global leader in myopia management, has kicked off its 2022 Myopia Management Workshop series. The immersive full-day events are designed to accelerate practices’ clinical and business success in the fast-growing sector.

BHVI Launches Myopia Awareness Week 2022

By Staff
Tuesday, May 10, 2022 12:15 AM SYDNEY, Australia—BHVI (Brien Holden Vision Institute), the Australian not-for-profit organization with an international focus on vision research, has announced the launch of Myopia Awareness Week for 2022, a global initiative relaunched in 2021, to bring attention to the growing epidemic of myopia in children across the world.

MyVision Study Reveals Eye Issues Related to Pandemic

By Staff
Monday, May 9, 2022 12:50 PM The COVID pandemic has led to a growing number of eye issues over the last two years, according to the results of a new consumer survey conducted by MyVision.org, a group of expert ophthalmologists and optometrists whose purpose is to provide trusted information on eye health and vision. The organization polled more than 1,121 people who wear glasses and/or contacts to get feedback on their eye health and eye habits throughout the past few years.

STAAR Surgical Posts 1Q Net Sales $63.2 Million, Up 25 Percent Year-on-Year

By Staff
Monday, May 9, 2022 12:18 AM LAKE FOREST, Calif.—STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, reported record net sales of $63.2 million for the first quarter ended April 1, 2022, a 25 percent increase over the prior year quarter.

Hoya Reports Positive Results From Six-Year MiYoSmart Clinical Study

By Staff
Friday, May 6, 2022 12:24 AM BANGKOK—Hoya Vision Care announced yesterday that it has obtained positive results from a six-year clinical study of its MiYoSmart spectacle lens with Defocus Incorporated Multiple Segments (D.I.M.S.) Technology. The research findings were shared at the Association for Research in Vision and Ophthalmology (ARVO) 2022 conference in Denver, Colo. by Professor Carly Lam from the Centre for Myopia Research at The Hong Kong Polytechnic University. Professor Lam conducted the research, which is the longest study on a myopia management spectacle lens to date.